Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in this report.

The global Chickenpox Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chickenpox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chickenpox Vaccine.

Report Scope

The Chickenpox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chickenpox Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chickenpox Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chickenpox Vaccine Market Report

Report Metric	Details
Report Name	Chickenpox Vaccine Market
CAGR	5%
Segment by Type	Monovalent Vaccine Combination Vaccine
Segment by Application	Kids Injection Adults Injection
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chickenpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chickenpox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chickenpox Vaccine Market report?

Ans: The main players in the Chickenpox Vaccine Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Chickenpox Vaccine Market report?

Ans: The Applications covered in the Chickenpox Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Chickenpox Vaccine Market report?

Ans: The Types covered in the Chickenpox Vaccine Market report are Monovalent Vaccine, Combination Vaccine

1 Chickenpox Vaccine Market Overview

1.1 Product Overview and Scope of Chickenpox Vaccine

1.2 Chickenpox Vaccine Segment by Type

1.2.1 Global Chickenpox Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Monovalent Vaccine

1.2.3 Combination Vaccine

1.3 Chickenpox Vaccine Segment by Application

1.3.1 Global Chickenpox Vaccine Market Value by Application: (2024-2030)

1.3.2 Kids Injection

1.3.3 Adults Injection

1.4 Global Chickenpox Vaccine Market Size Estimates and Forecasts

1.4.1 Global Chickenpox Vaccine Revenue 2019-2030

1.4.2 Global Chickenpox Vaccine Sales 2019-2030

1.4.3 Global Chickenpox Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Chickenpox Vaccine Market Competition by Manufacturers

2.1 Global Chickenpox Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Chickenpox Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Chickenpox Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Chickenpox Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chickenpox Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chickenpox Vaccine, Product Type & Application

2.7 Chickenpox Vaccine Market Competitive Situation and Trends

2.7.1 Chickenpox Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Chickenpox Vaccine Players Market Share by Revenue

2.7.3 Global Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Chickenpox Vaccine Retrospective Market Scenario by Region

3.1 Global Chickenpox Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Chickenpox Vaccine Global Chickenpox Vaccine Sales by Region: 2019-2030

3.2.1 Global Chickenpox Vaccine Sales by Region: 2019-2024

3.2.2 Global Chickenpox Vaccine Sales by Region: 2025-2030

3.3 Global Chickenpox Vaccine Global Chickenpox Vaccine Revenue by Region: 2019-2030

3.3.1 Global Chickenpox Vaccine Revenue by Region: 2019-2024

3.3.2 Global Chickenpox Vaccine Revenue by Region: 2025-2030

3.4 North America Chickenpox Vaccine Market Facts & Figures by Country

3.4.1 North America Chickenpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Chickenpox Vaccine Sales by Country (2019-2030)

3.4.3 North America Chickenpox Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Chickenpox Vaccine Market Facts & Figures by Country

3.5.1 Europe Chickenpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Chickenpox Vaccine Sales by Country (2019-2030)

3.5.3 Europe Chickenpox Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chickenpox Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Chickenpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Chickenpox Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Chickenpox Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Chickenpox Vaccine Market Facts & Figures by Country

3.7.1 Latin America Chickenpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Chickenpox Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Chickenpox Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chickenpox Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Chickenpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Chickenpox Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Chickenpox Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chickenpox Vaccine Sales by Type (2019-2030)

4.1.1 Global Chickenpox Vaccine Sales by Type (2019-2024)

4.1.2 Global Chickenpox Vaccine Sales by Type (2025-2030)

4.1.3 Global Chickenpox Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Chickenpox Vaccine Revenue by Type (2019-2030)

4.2.1 Global Chickenpox Vaccine Revenue by Type (2019-2024)

4.2.2 Global Chickenpox Vaccine Revenue by Type (2025-2030)

4.2.3 Global Chickenpox Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Chickenpox Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Chickenpox Vaccine Sales by Application (2019-2030)

5.1.1 Global Chickenpox Vaccine Sales by Application (2019-2024)

5.1.2 Global Chickenpox Vaccine Sales by Application (2025-2030)

5.1.3 Global Chickenpox Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Chickenpox Vaccine Revenue by Application (2019-2030)

5.2.1 Global Chickenpox Vaccine Revenue by Application (2019-2024)

5.2.2 Global Chickenpox Vaccine Revenue by Application (2025-2030)

5.2.3 Global Chickenpox Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Chickenpox Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Chickenpox Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Chickenpox Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Shanghai Institute

6.3.1 Shanghai Institute Corporation Information

6.3.2 Shanghai Institute Description and Business Overview

6.3.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Shanghai Institute Chickenpox Vaccine Product Portfolio

6.3.5 Shanghai Institute Recent Developments/Updates

6.4 BCHT

6.4.1 BCHT Corporation Information

6.4.2 BCHT Description and Business Overview

6.4.3 BCHT Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 BCHT Chickenpox Vaccine Product Portfolio

6.4.5 BCHT Recent Developments/Updates

6.5 Changsheng

6.5.1 Changsheng Corporation Information

6.5.2 Changsheng Description and Business Overview

6.5.3 Changsheng Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Changsheng Chickenpox Vaccine Product Portfolio

6.5.5 Changsheng Recent Developments/Updates

6.6 Keygen

6.6.1 Keygen Corporation Information

6.6.2 Keygen Description and Business Overview

6.6.3 Keygen Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Keygen Chickenpox Vaccine Product Portfolio

6.6.5 Keygen Recent Developments/Updates

6.7 Green Cross

6.6.1 Green Cross Corporation Information

6.6.2 Green Cross Description and Business Overview

6.6.3 Green Cross Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Green Cross Chickenpox Vaccine Product Portfolio

6.7.5 Green Cross Recent Developments/Updates

6.8 Biken

6.8.1 Biken Corporation Information

6.8.2 Biken Description and Business Overview

6.8.3 Biken Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Biken Chickenpox Vaccine Product Portfolio

6.8.5 Biken Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chickenpox Vaccine Industry Chain Analysis

7.2 Chickenpox Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chickenpox Vaccine Production Mode & Process

7.4 Chickenpox Vaccine Sales and Marketing

7.4.1 Chickenpox Vaccine Sales Channels

7.4.2 Chickenpox Vaccine Distributors

7.5 Chickenpox Vaccine Customers

8 Chickenpox Vaccine Market Dynamics

8.1 Chickenpox Vaccine Industry Trends

8.2 Chickenpox Vaccine Market Drivers

8.3 Chickenpox Vaccine Market Challenges

8.4 Chickenpox Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Chickenpox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Chickenpox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Chickenpox Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Chickenpox Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Chickenpox Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Chickenpox Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Chickenpox Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Chickenpox Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Chickenpox Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chickenpox Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chickenpox Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Chickenpox Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chickenpox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chickenpox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Chickenpox Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Chickenpox Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Chickenpox Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Chickenpox Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Chickenpox Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Chickenpox Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Chickenpox Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Chickenpox Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Chickenpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Chickenpox Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Chickenpox Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Chickenpox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Chickenpox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Chickenpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Chickenpox Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Chickenpox Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Chickenpox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Chickenpox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Chickenpox Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Chickenpox Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Chickenpox Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Chickenpox Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Chickenpox Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Chickenpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Chickenpox Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Chickenpox Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Chickenpox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chickenpox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chickenpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Chickenpox Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Chickenpox Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Chickenpox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Chickenpox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Chickenpox Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Chickenpox Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Chickenpox Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Chickenpox Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Chickenpox Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Chickenpox Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Chickenpox Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Chickenpox Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Chickenpox Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Chickenpox Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Chickenpox Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Chickenpox Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Chickenpox Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Chickenpox Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Chickenpox Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Chickenpox Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Chickenpox Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Chickenpox Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Chickenpox Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Chickenpox Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Merck Chickenpox Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. GSK Corporation Information

Table 76. GSK Description and Business Overview

Table 77. GSK Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. GSK Chickenpox Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Shanghai Institute Corporation Information

Table 81. Shanghai Institute Description and Business Overview

Table 82. Shanghai Institute Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Shanghai Institute Chickenpox Vaccine Product

Table 84. Shanghai Institute Recent Developments/Updates

Table 85. BCHT Corporation Information

Table 86. BCHT Description and Business Overview

Table 87. BCHT Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. BCHT Chickenpox Vaccine Product

Table 89. BCHT Recent Developments/Updates

Table 90. Changsheng Corporation Information

Table 91. Changsheng Description and Business Overview

Table 92. Changsheng Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Changsheng Chickenpox Vaccine Product

Table 94. Changsheng Recent Developments/Updates

Table 95. Keygen Corporation Information

Table 96. Keygen Description and Business Overview

Table 97. Keygen Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Keygen Chickenpox Vaccine Product

Table 99. Keygen Recent Developments/Updates

Table 100. Green Cross Corporation Information

Table 101. Green Cross Description and Business Overview

Table 102. Green Cross Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Green Cross Chickenpox Vaccine Product

Table 104. Green Cross Recent Developments/Updates

Table 105. Biken Corporation Information

Table 106. Biken Description and Business Overview

Table 107. Biken Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Biken Chickenpox Vaccine Product

Table 109. Biken Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Chickenpox Vaccine Distributors List

Table 113. Chickenpox Vaccine Customers List

Table 114. Chickenpox Vaccine Market Trends

Table 115. Chickenpox Vaccine Market Drivers

Table 116. Chickenpox Vaccine Market Challenges

Table 117. Chickenpox Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Chickenpox Vaccine

Figure 2. Global Chickenpox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Chickenpox Vaccine Market Share by Type in 2023 & 2030

Figure 4. Monovalent Vaccine Product Picture

Figure 5. Combination Vaccine Product Picture

Figure 6. Global Chickenpox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Chickenpox Vaccine Market Share by Application in 2023 & 2030

Figure 8. Kids Injection

Figure 9. Adults Injection

Figure 10. Global Chickenpox Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Chickenpox Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Chickenpox Vaccine Sales (2019-2030) & (K Doses)

Figure 13. Global Chickenpox Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 14. Chickenpox Vaccine Report Years Considered

Figure 15. Chickenpox Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Chickenpox Vaccine Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Chickenpox Vaccine Players: Market Share by Revenue in 2023

Figure 18. Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Chickenpox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Chickenpox Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Chickenpox Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Chickenpox Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Chickenpox Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Chickenpox Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Chickenpox Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Chickenpox Vaccine Sales Market Share by Country (2019-2030)

Figure 44. Latin America Chickenpox Vaccine Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Chickenpox Vaccine Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Chickenpox Vaccine Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Chickenpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Chickenpox Vaccine by Type (2019-2030)

Figure 54. Global Revenue Market Share of Chickenpox Vaccine by Type (2019-2030)

Figure 55. Global Chickenpox Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 56. Global Sales Market Share of Chickenpox Vaccine by Application (2019-2030)

Figure 57. Global Revenue Market Share of Chickenpox Vaccine by Application (2019-2030)

Figure 58. Global Chickenpox Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 59. Chickenpox Vaccine Value Chain

Figure 60. Chickenpox Vaccine Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions